← back to search

Nadja Kopp

Dana-Farber Cancer Institute · US
Area of research
Genetics · Pathology and Forensic Medicine
Research interest
Research interests include Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment, Monoclonal and Polyclonal Antibodies Research, and PARP inhibition in cancer therapy.
h-index
17
citations
2,738
works
80
NIH funding
primary concept
email

Recent publications

The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice
Cancer Cell 2016cited by 303position: middledoi
Clonal evolution in relapsed and refractory diffuse large B-cell lymphoma is characterized by high dynamics of subclones
Oncotarget 2016cited by 44position: middledoi
HSP90 inhibition overcomes ibrutinib resistance in mantle cell lymphoma
Blood 2016cited by 42position: middledoi
Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry
The Lancet Oncology 2015cited by 610position: middledoi
Mutations in G protein β subunits promote transformation and kinase inhibitor resistance
Nature Medicine 2014cited by 102position: middledoi
Low frequency clonal mutations recoverable by deep sequencing in patients with aplastic anemia
Leukemia 2013cited by 70position: middledoi
BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia
Blood 2012cited by 369position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

David M. Weinstock · Harvard University4 papers (2012–2016)Scott J. Rodig · Massachusetts Institute of Technology3 papers (2012–2016)Oliver Weigert · München Klinik2 papers (2016–2016)Liat Bird · University of California, San Francisco2 papers (2012–2016)Rachel Erlich · Blueprint Medicines (United States)1 papers (2013–2013)Lukas Weiß · Hebrew University of Jerusalem1 papers (2016–2016)Sarah Haebe · LMU Klinikum1 papers (2016–2016)Daniel Neureiter · Unfallkrankenhaus Salzburg1 papers (2016–2016) · 1 papers (2016–2016)Robert Redd · Massachusetts General Hospital1 papers (2016–2016)Oreofe O. Odejide · Harvard University1 papers (2013–2013)Teresa V. Bowman · Albert Einstein College of Medicine1 papers (2012–2012)Jacob V. Layer · Indiana University – Purdue University Indianapolis1 papers (2016–2016)Ronald M. Paranal · Fred Hutch Cancer Center1 papers (2012–2012)Caron A. Jacobson · Harvard University1 papers (2016–2016)Amanda L. Christie · Massachusetts Institute of Technology1 papers (2016–2016) · 1 papers (2016–2016)Richard Greil · EB House Austria1 papers (2016–2016) · 1 papers (2016–2016) · 1 papers (2016–2016)